Maria P. Gorenflo

Oct 17, 2024 | medrxiv.org | Pingjian Ding |Zhenxiang Gao |Maria P. Gorenflo |Rong Xu

The authors have declared no competing interest. This work was funded by the National Institute on Aging (AG057557, AG061388, AG062272, AG07664), and the National Institute on Alcohol Abuse and Alcoholism (AA029831). I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Feb 14, 2023 | medrxiv.org | Pamela Davis |David C. Kaelber |Rong Xu |Maria P. Gorenflo

AbstractImportance The Centers for Disease Control and Prevention (CDC) announced in January 2023 that they were investigating a potential connection between administration of the Pfizer novel coronavirus disease-2019 (COVID-19) bivalent vaccine booster and ischemic stroke (IS). Objective To explore the relationship between Pfizer bivalent booster administration and IS in older patients in the United States and compare it to other COVID-19 vaccines.